Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
clinical trials
detroit blog main
2
×
detroit top stories
eli lilly
gene therapy
indiana blog main
indiana top stories
life sciences
medicare
merck
2
×
migraine
2
×
national
national blog main
national top stories
new york blog main
new york top stories
nivolumab
pembrolizumab
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
adalimumab (humira)
aducanumab
What
bio
companies
roundup
approval
arena’s
biogen’s
biopharmaceutical
bounty
cig
comeback
convo
corner
deals
delivered
drug
earlier
expressing
failures
ipo
life
littered
little
moderna’s
nash
new
news
number
price
remains
road
science
strategy
survey
talk
thanks
thanksgiving
week
Language
Current search:
migraine
×
merck
×
" detroit blog main "
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More